Studies on the differential sensitivity between diabetic and non-diabetic human erythrocytes to monoacetyl dapsone hydroxylamine-mediated methaemoglobin formation in vitro

Environmental Toxicology and Pharmacology

Volumn 1, Issue 2, 1996, Pages 97-102

  Coleman, Michael D ^a   Ogg, Malcolm S ^a,d   Holmes, Jan L ^a   Gardiner, John M ^b   Jacobus, David P ^c  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Jacobus Pharmaceutical Co Inc   (United States)

^d UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Diabetic; hemoglobin; Monoacetyl dapsone hydroxylamine; Non diabetic; Sensitivity

Indexed keywords

CYTOCHROME B5 REDUCTASE; GLUCOSE; GLUTATHIONE; HEMOGLOBIN; METHEMOGLOBIN; MONOACETYLDAPSONE HYDROXYLAMINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL TYPE; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG SYNTHESIS; ERYTHROCYTE; HEMOLYSATE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; METHEMOGLOBINEMIA; PRIORITY JOURNAL;

EID: 0030013565     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/1382-6689(95)00013-5     Document Type: Article

References (30)

1. Anderson, M.E., 1985, Determination of glutathione and glutathione disulfide in biological samples, Methods Enzymol. 113, 549.
2. Banzato, C.E.M. and L.A. Magna, 1991, In vitro effect of dapsone on NADH-methaemoglobin reductase, Int. J. Leprosy 59, 486.
3. Blakynty, R. and J.J. Harding, 1992, Glycation (non-enzymatic glycosylation) inactivates glutathione reductase, Biochem. J. 288, 303.
4. Coleman, M.D. and D.P. Jacobus, 1993, Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro, Biochem. Pharmacol. 45, 1027.
5. Coleman, M.D., A.K. Scott, A.M. Breckenridge and B.K. Park, 1990, The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man, Br. J. Clin. Pharmacol. 30, 761.
6. Coleman, M.D., J. Simpson and D.P. Jacobus, 1994, Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro III: effect of diabetes, Biochem. Pharmacol. 48, 1341.
7. Collier, A., R. Wilson, H. Bradley, J.A. Thomson and M. Small, 1990, Free radicals in type II diabetes, Diabetes Med. 7, 27
8. Costagliola, C., 1990, Oxidative state of glutathione in red blood cells and plasma of diabetic patients: in vivo and in vitro study, Clin. Physiol. Biochem. 8, 204.
9. Elashoff, J.D., 1981, Down with multiple 't' tests, Gastroenterology 80, 615.
10. Gonen, B., A.H. Rubinstein, H. Rochman, S.F. Tenaga and D.L. Horwitz, 1977, Haemoglobin Al, an indicator of the metabolic control of diabetic patients, Lancet ii, 734.
11. Grossman, S.J., J. Stimson and D.J. Jollow, 1992, Dapsone-induced hemolytic anemia: effect of N-hydroxydapsone on the sulfhydryl status and membrane proteins of rat erythrocytes, Toxicol. Appl. Pharmacol. 117, 208.
12. Hennessey, M.A., A.M. Waltersdorf, F.M. Huennekens and B.W. Gabrio, 1962, Erythrocyte metabolism. VI. Separation of erythrocyte enzymes from hemaglobin, J. Clin. Invest. 41, 1257.
13. Jacson, R.C., 1969, Studies in enzymology of glutathione metabolism in human erythrocytes, Biochem. J. 111, 309.
14. Job, A., S. Venkatesawaran, M. Mathan, H. Krishnaswami and R. Raman, 1993, Medical therapy of rhinosporidiosis with dapsone, J. Laryngol. Otol. 107, 809.
15. Jocelyn, P.C., 1972, Biochemistry of the SH Groups (Academic Press, London) p. 247.
16. Kramer, P.A., B.E. Glader and T.K. Li, 1972, Mechanism of methaemoglobin formation by diphenylsulphones, Biochem. Pharmacol. 21, 1265.
17. Manfredi, G., G. De Panfilis, M. Zampetti and F. Allegra, 1979, Studies on dapsone-induced haemolytic anaemia: methaemoglobin production and glucose 6-phosphate activity in correlation with dapsone dosage, Br. J. Dermatol. 100, 427.
18. McLennan, S.V., S. Hefferman, L. Wright, C. Rac, E. Fisher, D.K. Yene and J. Turtle, 1991, Changes in hepatic glutathione metabolims in diabetics, Diabetes 40, 344.
19. McLennan, A.C., P.J. Thornaly, J. Benn and P.H. Sonksen, 1994, Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications, Clin. Sci. 87, 21.
20. Murakami, K., T. Kondo, Y Ohtsuka, Y. Fujiwara, M. Shimada and Y. Kawakami, 1989, Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus, Metabolism 38, 753.
21. Paolisso, G., G. Di Maro, G. Pizza, A. D'Amore, S. Sgambato, P. Tesauro, M. Varrichio and F. D'Onofrio, 1992, PLasma GSH/GSSG affects glucose homeostasis in healthy subjects and non-insulin-dependent diabetics, Am. J. Physiol. 263 (Endocrinol. Metab. 26), E435.
22. Piscitelli, S.C., D.J. Occhipinti, L.H. Danziger, C. Hill, D.P. West and J.H. Fischer, 1993, Therapeutic monitoring and pharmacist intervention in a Hansens' disease clinic, Ann. Pharmacother. 27, 1526.
23. Sagone, A.L., S.P. Balcerzak and E.N. Metz, 1975, The response of red cell hexose monophosphate shunt after sulfhydryl inhibition, Blood 45, 49.
24. Scott, E.M., 1960 The relation of diaphorase of human erythrocytes to inheritance of methemoglobinemia, J. Clin. Invest. 39, 1176.
25. Scott, G.L and M.R. Rasbridge, 1973, The in vitro action of dapsone and its derivatives on normal and G6PD-deficient red cells, Br. J. Haematol. 24, 307.
26. Smith, E.P. and J.J. Zone, 1993, Dermatitis herpetiformis and linear IgA bullous dermatitis, Dermatol. Clin. 11, 511.
27. Spielberg, S.P., 1980, Acetominophen toxicity in human leucocytes in vitro, J. Pharm. Exp. Ther. 213, 393.
28. Torres, R.A., M. Barr, M. Thorn, G. Gregory, K. Wiely, E. Chanin, C. Carlo, M. Nartin and J. Thornton, 1993, Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis, Am. J. Med. 95, 573.
29. Vage, C., N. Saab, P.M. Woster and C.K. Svensson, 1994, Dapsone-induced hematologic toxicity-comparison of the methemoglobin forming ability of hydroxylamine metabolites of dapsone in rat and human blood, Toxicol. Appl. Pharmacol. 129, 309.
30. Vrbova, H, S. Gibney, F.D. Gibson, D. Jolley, P.F. Heywood, J. Stace, F.R. Trenholme and M.P. Alpers, M.P., 1992, Chemoprophylaxis against malaria in Papua New Guinea: a trial of amiodiaquine and a combination of dapsone and pyrimethamine, Papua New Guinea Med. J. 35, 275.